
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integrins regulate stemness in solid tumor: an emerging therapeutic target
Jiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 64
Jiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 260
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 260
Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling
Cong Li, Shi Qiu, Xiaohan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Cong Li, Shi Qiu, Xiaohan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65
Nanoparticle-based drug delivery systems targeting cancer cell surfaces
Liquan Hong, Wen Li, Yang Li, et al.
RSC Advances (2023) Vol. 13, Iss. 31, pp. 21365-21382
Open Access | Times Cited: 55
Liquan Hong, Wen Li, Yang Li, et al.
RSC Advances (2023) Vol. 13, Iss. 31, pp. 21365-21382
Open Access | Times Cited: 55
Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 54
Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 53
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 53
Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy
Jiaqiang Xiong, Rourou Xiao, Jiahui Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Jiaqiang Xiong, Rourou Xiao, Jiahui Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Magnetic Nanoactuator-Protein Fiber Coated Hydrogel Dressing for Well-Balanced Skin Wound Healing and Tissue Regeneration
Chenlong He, Ming Yin, Han Zhou, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Chenlong He, Ming Yin, Han Zhou, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 6
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 6
Integrin β1 regulates the perineural invasion and radioresistance of oral squamous carcinoma cells by modulating cancer cell stemness
Sung Joon Park, Hyun Jin Min, Changhwan Yoon, et al.
Cellular Signalling (2023) Vol. 110, pp. 110808-110808
Closed Access | Times Cited: 15
Sung Joon Park, Hyun Jin Min, Changhwan Yoon, et al.
Cellular Signalling (2023) Vol. 110, pp. 110808-110808
Closed Access | Times Cited: 15
Targeting extracellular matrix through phytochemicals: a promising approach of multi-step actions on the treatment and prevention of cancer
Dan Liang, Lu Liu, Yunjie Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Dan Liang, Lu Liu, Yunjie Zhao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Interaction of integrin αvβ3 and fibronectin under fluid shear forces: implications for tumor cell adhesion and migration
Paimin Zhuo, Quhuan Li, Bishan Yang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Paimin Zhuo, Quhuan Li, Bishan Yang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets
Zonghao Liu, Xiaofang Zhang, Theresa Ben, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Zonghao Liu, Xiaofang Zhang, Theresa Ben, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications
Yoshinobu Kariya, Michiru Nishita
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3143-3143
Open Access
Yoshinobu Kariya, Michiru Nishita
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3143-3143
Open Access
Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer
Meiling Zhang, Bin Zhang
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Meiling Zhang, Bin Zhang
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK/Src axis
Zhiwei Qin, Chongzhi Zhou
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16
Zhiwei Qin, Chongzhi Zhou
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16
SKAP2—A Molecule at the Crossroads for Integrin Signalling and Immune Cell Migration and Function
Marijn Wilmink, Marianne R. Spalinger
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2788-2788
Open Access | Times Cited: 10
Marijn Wilmink, Marianne R. Spalinger
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2788-2788
Open Access | Times Cited: 10
Nanotopographic micro-nano forces finely tune the conformation of macrophage mechanosensitive membrane protein integrin β2 to manipulate inflammatory responses
Yuanlong Guo, Yingfang Ao, Chen Ye, et al.
Nano Research (2023) Vol. 16, Iss. 7, pp. 9715-9729
Open Access | Times Cited: 9
Yuanlong Guo, Yingfang Ao, Chen Ye, et al.
Nano Research (2023) Vol. 16, Iss. 7, pp. 9715-9729
Open Access | Times Cited: 9
An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer
Mengjie Chen, Cheng Zou, Yu Tian, et al.
Oncogene (2024) Vol. 43, Iss. 21, pp. 1594-1607
Closed Access | Times Cited: 3
Mengjie Chen, Cheng Zou, Yu Tian, et al.
Oncogene (2024) Vol. 43, Iss. 21, pp. 1594-1607
Closed Access | Times Cited: 3
Developing a dormancy-associated ECM signature in TNBC that is linked to immunosuppressive tumor microenvironment and selective sensitivity to MAPK inhibitors
Dong Yang, Jin Bai, Jianjun Zhou
Heliyon (2024) Vol. 10, Iss. 11, pp. e32106-e32106
Open Access | Times Cited: 3
Dong Yang, Jin Bai, Jianjun Zhou
Heliyon (2024) Vol. 10, Iss. 11, pp. e32106-e32106
Open Access | Times Cited: 3
Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: Mechanistic insights and biomaterial platforms
Delaram Shakiba, Guy M. Genin, Silviya P. Zustiak
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114771-114771
Open Access | Times Cited: 9
Delaram Shakiba, Guy M. Genin, Silviya P. Zustiak
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114771-114771
Open Access | Times Cited: 9
Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review
Wuhao Wei, Yuansheng Zhang, Zhizhe Lin, et al.
Journal of drug targeting (2022) Vol. 31, Iss. 1, pp. 1-13
Closed Access | Times Cited: 10
Wuhao Wei, Yuansheng Zhang, Zhizhe Lin, et al.
Journal of drug targeting (2022) Vol. 31, Iss. 1, pp. 1-13
Closed Access | Times Cited: 10
The Role of Integrins for Mediating Nanodrugs to Improve Performance in Tumor Diagnosis and Treatment
Chi Yu, Wei Jiang, Bin Li, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1721-1721
Open Access | Times Cited: 6
Chi Yu, Wei Jiang, Bin Li, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1721-1721
Open Access | Times Cited: 6